Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05488782 · ClinicalTrials.gov registry record · NA
TEAM-Red, a Remotely Delivered Self-management Program for Depressed Black Women at Risk for Hypertension
A NA study of Depression, sponsored by Jennifer B. Levin.
- Active
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT05488782: Active NA study of Depression, sponsored by Jennifer B. Levin.
NCT05488782 is a NA study of Depression that is active but no longer recruiting, run by Jennifer B. Levin. The registered enrollment target is 82 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05488782, a NA study of Depression, is active but no longer recruiting, sponsored by Jennifer B. Levin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (\<50 years) African American women who are depressed or suffering from stress, and at risk for hypertension.
Primary Outcome
PHQ-9 total score ranges from 0 to 27, with a higher score indicating a higher level depression
Conditions Studied
Interventions
- OTHER Waitlist
- BEHAVIORAL TEAM-Red
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2023-01-30 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05488782 still lists
NCT05488782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Waitlist is the first listed.
NCT05488782 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05488782 about?
NCT05488782 is a clinical study titled "TEAM-Red, a Remotely Delivered Self-management Program for Depressed Black Women at Risk for Hypertension". The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (\<50 years) African American women who are depressed or suffering from stress, and at risk for h...
What is the current status of trial NCT05488782?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 82 participants. The study started on 2023-01-30. Estimated completion is 2026-06-30.
What conditions does trial NCT05488782 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT05488782?
The interventions under investigation include: Waitlist (OTHER), TEAM-Red (BEHAVIORAL).
Who is sponsoring clinical trial NCT05488782?
This trial is sponsored by Jennifer B. Levin, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05488782 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05488782's enrollment target sits among peer trials
82 370th of 679 higher than 309 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy